Evidence map›Paper›PMID 36067369›Full record

Trial reportThe Journal of urology2023

Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial.

Alayne D Markland, Camille P Vaughan, Alison J Huang, Eunjung Kim, Vadim Y Bubes, Vin Tangpricha, Julie R Buring, I-Min Lee, Nancy R Cook, JoAnn E Manson and 1 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05709990 (Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05709990 nacompletednot on this map

Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children: A Randomized Clinical Trial

TypeinterventionalSponsorXing LiuRan2023 to 2023Enrolled303ConditionsOveractive BladderArmsSolifenacin Succinate 5 MG Oral Tablet [Vesicare], Vitamin D3, Standard urotherapy
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Alayne D MarklandBirmingham/Atlanta Geriatric Research, Education, and Clinical Center (GRECC), Department of Veterans Affairs, Birmingham, Alabama and Atlanta, Georgia.
Camille P VaughanBirmingham/Atlanta Geriatric Research, Education, and Clinical Center (GRECC), Department of Veterans Affairs, Birmingham, Alabama and Atlanta, Georgia.
Alison J HuangUniversity of California, San Francisco, Department of Medicine, San Francisco, California.
Eunjung KimDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Vadim Y BubesDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Vin TangprichaEmory University Department of Medicine, Atlanta, Georgia.
Julie R BuringDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
I-Min LeeDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Nancy R CookDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JoAnn E MansonDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Francine GrodsteinRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.
Harvard University · USBrigham and Women's Hospital · USEmory University · USRush University Medical Center · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
VITamin D and omegA-3 triaL (VITAL)U01CA138962 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., MANSON, JOANN ELISABETH · 2009 to 2014
$23.6M
The VITamin D and OmegA-3 TriaL (VITAL)R01CA138962 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., MANSON, JOANN ELISABETH · 2015 to 2019
$20.9M
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-UpR01AT011729 · NCCIH · BRIGHAM AND WOMEN'S HOSPITAL · PI Jun Li, JoAnn Elisabeth Manson · 2021 to 2026
$5.2M
Role of Vitamin D in the Prevention and Progression of Urinary IncontinenceR01DK115473 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARKLAND, ALAYNE DENISE · 2018 to 2021
$1.4M
Patient-Oriented Research and Mentoring in Genitourinary AgingK24AG068601 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alison Huang · 2020 to 2026
$1.2M
Research and Mentoring Program in Improving Access to Incontinence Care for Older AdultsK24AG073586 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Alayne Denise Markland · 2022 to 2026
$619k
NCATS NIH HHS UL1 TR002378NCCIH NIH HHS R01 AT011729NCI NIH HHS R01 CA138962NCI NIH HHS U01 CA138962NIA NIH HHS K24 AG068601NIA NIH HHS K24 AG073586NIDDK NIH HHS R01 DK115473
6 · The paper itself

Abstract

purposeOur goal was to evaluate vitamin D supplementation for preventing or treating overactive bladder and urinary incontinence in men. MATERIALS AND

methodsAncillary study of men aged ≥55 years in VITAL (VITamin D and OmegA-3 TriaL). Randomized treatments included: vitamin D

resultsAmong the 11,486 men who provided data at year 2 and 10,474 at year 5, mean age was 68 years at year 2, with 23% racial/ethnic minorities. In primary analyses, vitamin D supplementation compared to placebo did not lower odds of overactive bladder at year 5 (OR 0.97, 95% CI 0.87-1.08) or weekly urinary incontinence at year 2 (OR 0.94, 95% CI 0.83-1.05) or year 5 (OR 0.98, 95% CI 0.88-1.09). We found interactions of baseline serum 25-hydroxyvitamin D level with vitamin D supplementation for overactive bladder (

conclusionsOverall, vitamin D supplementation did not improve overactive bladder or urinary incontinence compared to placebo. However, specific use of vitamin D in men with lower 25-hydroxyvitamin D levels had inconsistent findings.

Indexed as

Urinary Bladder, OveractiveUrinary IncontinenceAgedHumansVitamin DVitamin Depidemiologylower urinary tract symptomsmenurinary incontinencevitamin D

Identifiers

PMID36067369
PMCPMC9742141
OpenAlexW4294816813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.